Coral Laboratories board meets Sep 25 to approve FY26 cost audit
- Board meeting scheduled for September 25, 2026
- Agenda includes approval of FY26 cost audit report
- Intimation issued under SEBI LODR Regulation 29
- Signed by Director and CFO Sushma Kadkade

*this image is generated using AI for illustrative purposes only.
Coral Laboratories will hold a board meeting on Friday, September 25, 2026, to approve its cost audit report for the financial year 2025-26.
The company notified the BSE Limited regarding the meeting pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Agenda
The Board of Directors is scheduled to consider and approve the following items:
- Cost Audit report for the financial year 2025-26
- Any other business with the permission of the chairman
Sushma Kadkade, Director and CFO, signed the intimation on September 21, 2026.
Historical Stock Returns for Coral Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.71% | -3.25% | -10.66% | +32.48% | +5.80% | 0.0% |
How might the findings in the FY 2025-26 cost audit report influence Coral Laboratories' pricing strategies and margin projections for the upcoming fiscal year?
Are there any anticipated regulatory implications or compliance adjustments for Coral Laboratories following the approval of this cost audit?
Could the cost audit results signal any operational inefficiencies that the board plans to address through strategic restructuring or technology investments?


































